CURX
NASDAQ · Pharmaceuticals
Curanex Pharmaceuticals Inc
$0.34
+0.02 (+7.16%)
Open$0.32
Previous Close$0.32
Day High$0.34
Day Low$0.30
52W High$9.18
52W Low$0.26
Volume—
Avg Volume143.8K
Market Cap8.95M
P/E Ratio—
EPS$-0.15
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.70M | 1.62M | 1.35M |
| Net Income | 499.2K | 484.2K | 288.0K |
| Profit Margin | 29.3% | 29.9% | 21.3% |
| EBITDA | 775.5K | 724.0K | 543.0K |
| Free Cash Flow | 289.5K | 292.3K | 286.4K |
| Rev Growth | +22.0% | +2.7% | +4.4% |
| Debt/Equity | 0.23 | 0.19 | 0.17 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |